Therapeutic non adherence: A rational behavior revealing patient preferences?
Download full text from publisherTo our knowledge, this item is not available for download. To find whether it is available, there are three options:
1. Check below whether another version of this item is available online.
2. Check on the provider's web page whether it is in fact available.
3. Perform a search for a similarly titled item that would be available.
Other versions of this item:
- Karine Lamiraud & Pierre-Yves Geoffard, 2007. "Therapeutic non-adherence: a rational behavior revealing patient preferences?," Health Economics, John Wiley & Sons, Ltd., vol. 16(11), pages 1185-1204.
- Karine Lamiraud & Pierre-Yves Geoffard, 2006. "Therapeutic non adherence: a rational behavior revealing patient preferences ?," PSE Working Papers halshs-00589121, HAL.
References listed on IDEAS
- Stern, S. & Trajtenberg, M., 1998.
"Empirical Implications of Physician Authority in Pharmaceutical Decisionmaking,"
24-98, Tel Aviv.
- Scott Stern & Manuel Trajtenberg, 1998. "Empirical Implications of Physician Authority in Pharmaceutical Decisionmaking," NBER Working Papers 6851, National Bureau of Economic Research, Inc.
- Clarke, Philip M., 1998. "Cost-benefit analysis and mammographic screening: a travel cost approach," Journal of Health Economics, Elsevier, vol. 17(6), pages 767-787, December.
- Spire, Bruno & Duran, Ségolène & Souville, Marc & Leport, Catherine & Raffi, François & Moatti, Jean-Paul, 2002. "Adherence to highly active antiretroviral therapies (HAART) in HIV-infected patients: from a predictive to a dynamic approach," Social Science & Medicine, Elsevier, vol. 54(10), pages 1481-1496, May.
- Conrad, Peter, 1985. "The meaning of medications: Another look at compliance," Social Science & Medicine, Elsevier, vol. 20(1), pages 29-37, January.
- Johansson, Per-Olov, 1997. "On the use of market prices to evaluate medical treatments," Journal of Health Economics, Elsevier, vol. 16(5), pages 609-615, October.
- Mundlak, Yair, 1978. "On the Pooling of Time Series and Cross Section Data," Econometrica, Econometric Society, vol. 46(1), pages 69-85, January.
- Bresnahan, Timothy F, 1986. "Measuring the Spillovers from Technical Advance: Mainframe Computers inFinancial Services," American Economic Review, American Economic Association, vol. 76(4), pages 742-755, September.
- Tomas Philipson & Larry V. Hedges, 1998. "Subject Evaluation in Social Experiments," Econometrica, Econometric Society, vol. 66(2), pages 381-408, March.
- Timothy F. Bresnahan & Robert J. Gordon, 1996. "The Economics of New Goods," NBER Books, National Bureau of Economic Research, Inc, number bres96-1, July.
- Paul Ellickson & Scott Stern & Manuel Trajtenberg, 2001.
"Patient Welfare and Patient Compliance -- An Empirical Framework for Measuring the Benefits from Pharmaceutical Innovation,"
NBER Chapters,in: Medical Care Output and Productivity, pages 539-564
National Bureau of Economic Research, Inc.
- Paul Ellickson & Scott Stern & Manuel Trajtenberg, 1999. "Patient Welfare and Patient Compliance: An Empirical Framework for Measuring the Benefits from Pharmaceutical Innovation," NBER Working Papers 6890, National Bureau of Economic Research, Inc.
- Ernst R. Berndt & Bronwyn H. Hall & Robert E. Hall & Jerry A. Hausman, 1974. "Estimation and Inference in Nonlinear Structural Models," NBER Chapters,in: Annals of Economic and Social Measurement, Volume 3, number 4, pages 653-665 National Bureau of Economic Research, Inc.
- Guilkey, David K. & Murphy, James L., 1993. "Estimation and testing in the random effects probit model," Journal of Econometrics, Elsevier, vol. 59(3), pages 301-317, October.
- Sickles, Robin C & Taubman, Paul, 1986.
"An Analysis of the Health and Retirement Status of the Elderly,"
Econometric Society, vol. 54(6), pages 1339-1356, November.
- Robin C. Sickles & Paul J. Taubman, 1984. "An Analysis of the Health and Retirement Status of the Elderly," NBER Working Papers 1459, National Bureau of Economic Research, Inc.
- Dyfrig A. Hughes & Adrian Bagust & Alan Haycox & Tom Walley, 2001. "The impact of non-compliance on the cost-effectiveness of pharmaceuticals: a review of the literature," Health Economics, John Wiley & Sons, Ltd., vol. 10(7), pages 601-615.
- James Robins & Andrea Rotnitzky & Stijn Vansteelandt, 2007. "Discussions," Biometrics, The International Biometric Society, vol. 63(3), pages 650-653, September.
- Cleemput, Irina & Kesteloot, Katrien & DeGeest, Sabina, 2002. "A review of the literature on the economics of noncompliance. Room for methodological improvement," Health Policy, Elsevier, vol. 59(1), pages 65-94, January.
CitationsCitations are extracted by the CitEc Project, subscribe to its RSS feed for this item.
- Nicolas Bouckaert & Erik Schokkaert, 2016.
"Differing types of medical prevention appeal to different individuals,"
The European Journal of Health Economics,
Springer;Deutsche Gesellschaft für Gesundheitsökonomie (DGGÖ), vol. 17(3), pages 317-337, April.
- BOUCKAERT, Nicolas & SCHOKKAERT, Erik, 2013. "Differing types of medical prevention appeal to different individuals," CORE Discussion Papers 2013038, Université catholique de Louvain, Center for Operations Research and Econometrics (CORE).
- Nicolas BOUCKAERT & Erik SCHOKKAERT, 2013. "Differing types of medical prevention appeal to different individuals," Working Papers Department of Economics ces13.11, KU Leuven, Faculty of Economics and Business, Department of Economics.
- Gajdos, Thibault & Garrouste, Clémentine & Geoffard, Pierre-Yves, 2016.
"The subjective value of a life with Down syndrome: Evidence from amniocentesis decision,"
Journal of Economic Behavior & Organization,
Elsevier, vol. 127(C), pages 59-69.
- Thibault Gajdos & Clémentine Garrouste & Pierre-Yves Geoffard, 2016. "The subjective value of a life with Down syndrome: Evidence from amniocentesis decision," PSE - Labex "OSE-Ouvrir la Science Economique" halshs-01314369, HAL.
- Mealem, Yosef & Siniver, Erez & Yaniv, Gideon, 2012. "Patient compliance, physician empathy and financial incentives within a principal-agent framework," Journal of Behavioral and Experimental Economics (formerly The Journal of Socio-Economics), Elsevier, vol. 41(6), pages 827-830.
More about this item
KeywordsHIV; Panel bivariate probit estimation; Endogenous adherence behavior; Drug valuation method; Revealed preferences;
StatisticsAccess and download statistics
All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:hal:journl:halshs-00754193. See general information about how to correct material in RePEc.
For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: (CCSD). General contact details of provider: https://hal.archives-ouvertes.fr/ .
If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.
If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.
Please note that corrections may take a couple of weeks to filter through the various RePEc services.